Table 2.
Variable | β | SE (β) | Odds ratio (95% CI) |
P value |
---|---|---|---|---|
PCA versus. MCA* | ||||
Model based on demographic, vascular risk, clinical, and topographic data* | ||||
Hemianopia | 1.861 | 0.212 | 6.43 (4.25-9.74) | 0.000 |
Lacunar infarction | 0.780 | 0.219 | 2.18 (1.42-3.35) | 0.000 |
Symptom-free at discharge | 0.653 | 0.230 | 1.92 (1.22-3.02) | 0.005 |
Limb weakness | -2.322 | 0.176 | 0.10 (0.07-0.14) | 0.000 |
Speech disorders (dysarthria) | -1.102 | 0.175 | 0.33 (0.24-0.47) | 0.000 |
Cardioembolic infarction | -0.436 | 0.214 | 0.65 (0.43-0.98) | 0.042 |
PCA versus ACA | ||||
Model based on demographic, vascular risk, clinical, and topographic data† | ||||
Sensory symptoms | 0.8610 | 0.363 | 2.36 (1.16-4.82) | 0.018 |
Limb weakness | -2.258 | 0.437 | 0.11 (0.04-0.25) | 0.000 |
Cardioembolic stroke | -0.856 | 0.352 | 0.43 (0.21-0.85) | 0.015 |
*β = -0.526; SE (β) = 0.203; goodness-of-fit χ2 = 0.016; df = 8; P = 0.016. Area under the ROC curve = 0.828; sensitivity 71.6%; specificity 80.4%; VPP 38.5%, VPN 94.3%, correct classification 79.1%.
†β = 2,937; SE (β) = 0.429; goodness-of-fit χ2 = 9.751; df = 6; P = 0.136. Area under the ROC curve = 0.803; sensitivity 73.3%; specificity 64.7%; VPP 90.4%, VPN 34.7%, correct classification 71.7%.